Patients are able to take the capsules at home
After consistent use, it refines uneven rough texture, fades visible dry lines and restores soft, youthful resilient complexion
The compound has not received IND (Investigational New Drug) designation from the FDA or CTA (Clinical Trial Authorisation) from the MHRA, meaning the regulatory-grade preclinical toxicology package if it exists is not publicly available
Male mice exposed to CMS for 2 weeks showed increased pathogenic bacteria including Acinetobacter, Proteus , and Enterococcus (Tyagi et al., 2025)
The two share the same three peptides at identical doses when inflammation is not a key issue to resolve, KLOW can be switched out for GLOW without regression during a 12-week protocol
Dehghani F, Sezavar Seyedi Jandaghi SH, Janani L, Sarebanhassanabadi M, Emamat H, Vafa M